CD8A and Guillain-Barre syndrome: This study provides a systematic description of CD4+ and CD8+ T cells targeting P0, P2 and PMP22 myelin antigens in the blood, CSF and nerve tissue of a well-characterized group of patients with GBS who have the demyelinating AIDP variant.